Prinicpal Investigators of the Innovative Medicines Initative’s PD-MitoQUANT project Olga Corti, Stéphane Hunot (both based at the Institut du Cerveau et de la Moelle Epinière ) and Luc Bousset (Centre National de la Recherche Scientifique) are on the organizing committee of the 2nd “pHysiopathology of Parkinson’s DisEase” (HOPE) conference taking place at the Institut du Cerveau et de la Moelle Epinière in Paris from 29 -31 January 2020.
The meeting will focus on the genetic and environmental determinants of Parkinson’s disease. Furthermore, their molecular mechanisms and modeling will be part of the scientific exchange. The aim of the conference is to promote a better understanding of the pathophysiology of the disease. In addition, the conference will aim to address new perspectives in the fields of preclinical, clinical, imaging and biomarker research.
European and French research in these fields has led to major advances. In some cases research even proposed new biomarkers and symptomatic treatments. At the clinical level, various meetings and networks such as French Clinical Research Infrastructure Network have emerged. Nevertheless, there is a need to promote similar initiatives on basic aspects of Parkinson’s disease pathophysiology and its modeling. This would greatly foster collaboration in this field and integration of basic and clinical research, whether academic, industrial, or linked to associations.
In addition, the Institut du Cerveau et de la Moelle Epinière proposes a workshop the first day on two topics that will be discussed during the congress: “Cellular modelling using microfluidic and stem cell technologies”, and “Available imaging tools for cellular models and to humans”.